GHTF clarifies ethical considerations in clinical studies guidance
This article was originally published in Clinica
Executive Summary
The Global Harmonization Task Force has underscored the significance of ethical considerations in the final version of its guidance on pre-market clinical investigations for medical devices. It has also provided clarifications on post-market clinical follow-up studies in a second guidance document.